Peter L. M. Jansen

20.1k total citations · 3 hit papers
196 papers, 13.7k citations indexed

About

Peter L. M. Jansen is a scholar working on Oncology, Epidemiology and Surgery. According to data from OpenAlex, Peter L. M. Jansen has authored 196 papers receiving a total of 13.7k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Oncology, 72 papers in Epidemiology and 58 papers in Surgery. Recurrent topics in Peter L. M. Jansen's work include Drug Transport and Resistance Mechanisms (68 papers), Liver Disease Diagnosis and Treatment (61 papers) and Pediatric Hepatobiliary Diseases and Treatments (34 papers). Peter L. M. Jansen is often cited by papers focused on Drug Transport and Resistance Mechanisms (68 papers), Liver Disease Diagnosis and Treatment (61 papers) and Pediatric Hepatobiliary Diseases and Treatments (34 papers). Peter L. M. Jansen collaborates with scholars based in Netherlands, United States and Germany. Peter L. M. Jansen's co-authors include Michael Trauner, Frank G. Schaap, Michael Müller, Ronald P.J. Oude Elferink, Han Moshage, Wilbert H.M. Peters, Folkert Kuipers, Ulrich Beuers, Piter J. Bosma and Harry van Goor and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Peter L. M. Jansen

192 papers receiving 13.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Genetic Basis of the Reduced Expression of Bilirubin UDP-Glucuronosyltransferase 1 in Gilbert's Syndrome

1995 1.1k citations Piter J. Bosma, Peter L. M. Jansen et al. profile →
Bile acid receptors as targets for drug development

2013 531 citations Frank G. Schaap, Michael Trauner et al. profile →
New paradigms in the treatment of hepatic cholestasis: From UDCA to FXR, PXR and beyond

2015 395 citations Ulrich Beuers, Michael Trauner et al. Journal of Hepatology profile →

Peers

Countries citing papers authored by Peter L. M. Jansen

Since Specialization

Citations

This map shows the geographic impact of Peter L. M. Jansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter L. M. Jansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter L. M. Jansen more than expected).

Fields of papers citing papers by Peter L. M. Jansen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter L. M. Jansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter L. M. Jansen. The network helps show where Peter L. M. Jansen may publish in the future.

Co-authorship network of co-authors of Peter L. M. Jansen

This figure shows the co-authorship network connecting the top 25 collaborators of Peter L. M. Jansen. A scholar is included among the top collaborators of Peter L. M. Jansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter L. M. Jansen. Peter L. M. Jansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Bile Salt and FGF19 Signaling in the Early Phase of Human Liver Regeneration 2021 ·Hepatology Communications ·(unknown), (unknown), Toine M. Lodewick, Johanne G. Bloemen, (unknown), Iakovos Amygdalos, Ulf P. Neumann, Cornelis H.C. Dejong, Peter L. M. Jansen, Steven W.M. Olde Damink, Frank G. Schaap	8
2	On the Mechanisms of Biliary Flux 2021 ·Hepatology ·Nachiket Vartak, Dirk Drasdo, Fabian Geisler, Tohru Itoh, Ronald P.J. Oude Elferink, Stan F.J. van de Graaf, John Y.L. Chiang, Verena Keitel, Michael Trauner, Peter L. M. Jansen, Jan G. Hengstler	10
3	Targeting the ileal bile salt transporter in the treatment of non-alcoholic fatty liver disease 2021 ·Hepatology International ·Peter L. M. Jansen	2
4	Effect of Plasmapheresis on Cholestatic Pruritus and Autotaxin Activity During Pregnancy 2019 ·Hepatology ·(unknown), (unknown), Hubertina Scheepers, Pieter van Paassen, Ad Masclee, Christine de Die‐Smulders, Steven W.M. Olde Damink, Frank G. Schaap, Peter L. M. Jansen, Ger H. Koek, Ulrich Beuers, Jef Verbeek	10
5	Gallbladder Dyskinesia Is Associated With an Impaired Postprandial Fibroblast Growth Factor 19 Response in Critically Ill Patients 2019 ·Hepatology ·(unknown), Mark P. Plummer, Frank G. Schaap, Martin Leníček, Peter L. M. Jansen, Adam M. Deane, Steven W.M. Olde Damink	10
6	FXR agonist obeticholic acid induces liver growth but exacerbates biliary injury in rats with obstructive cholestasis 2018 ·Scientific Reports ·Rowan F. van Golen, Pim B. Olthof, (unknown), Megan J. Reiniers, Lindy K. Alles, (unknown), (unknown), Bülent Ergin, Dirk R. de Waart, (unknown), Joanne Verheij, Peter L. M. Jansen, Steven W.M. Olde Damink, Frank G. Schaap, Thomas M. van Gulik, Michal Heger	29
7	Chronic elevation of plasma fibroblast growth factor 19 in long‐term farnesoid X receptor agonist therapy, a happy marriage or cause for oncological concern? 2017 ·Hepatology ·Frank G. Schaap, Peter L. M. Jansen, Steven W.M. Olde Damink	2
8	Characterization and treatment of persistent hepatocellular secretory failure 2014 ·Liver International ·Remco van Dijk, Andreas E. Kremer, Wouter L. Smit, (unknown), Thomas van Gulik, Dirk J. Gouma, Johan S. Laméris, Hennie Bikker, (unknown), Pieter Stokkers, (unknown), Piter J. Bosma, Peter L. M. Jansen, Ulrich Beuers	27
9	Fibroblast growth factor 21 is induced by endoplasmic reticulum stress 2012 ·Biochimie ·Frank G. Schaap, Andreas E. Kremer, Wouter H. Lamers, Peter L. M. Jansen, Ingrid C. Gaemers	139
10	Up-regulation and Cytoprotective Role of Epithelial Multidrug Resistance-associated Protein 1 in Inflammatory Bowel Disease 2008 ·Journal of Biological Chemistry ·Hans Blokzijl, (unknown), Sara Vander Borght, Lisette Bok, Louis Libbrecht, (unknown), Mariska Geuken, Tania Roskams, Gerard Dijkstra, Han Moshage, Peter L. M. Jansen, Klaas Nico Faber	30
11	Low retinol levels differentially modulate bile salt–induced expression of human and mouse hepatic bile salt transporters† 2008 ·Hepatology ·(unknown), Jacqueline Plass, Janette Heegsma, Mariska Geuken, (unknown), Julius F.W. Baller, Folkert Kuipers, Han Moshage, Peter L. M. Jansen, Klaas Nico Faber	25
12	Metformin protects hepatocytes against oxidative stress induced apoptosis via HO-1 induction and inhibition of JNK activation 2006 ·Hepatology ·Laura Conde de la Rosa, Titia E. Vrenken, Manon Buist‐Homan, Peter L. M. Jansen, Han Moshage	1
13	Bile acids induce hepatic stellate cell proliferation via activation of the epidermal growth factor receptor 2005 ·Gastroenterology ·Gianluca Svegliati‐Baroni, F. Ridolfi, Rebekka A. Hannivoort, S. Saccomanno, Manon Homan, Samuele De Minicis, Peter L. M. Jansen, C. Candelaresi, A. Benedetti, Han Moshage	131
14	Cytokine regulation of pro- and anti-apoptotic genes in rat hepatocytes: NF-κB-regulated inhibitor of apoptosis protein 2 (cIAP2) prevents apoptosis 2002 ·Journal of Hepatology ·Marieke H. Schoemaker, J.E. Ros, Manon Homan, Christian Trautwein, Peter Liston, Klaas Poelstra, Harry van Goor, Peter L. M. Jansen, Han Moshage	130
15	3-hydroxy-3-methylglutaryl–coenzyme a reductase inhibitors (statins) induce hepatic expression of the phospholipid translocase mdr2 in rats 1999 ·Gastroenterology ·Guido Hooiveld, (unknown), George L. Scheffer, Harry van Goor, Hans Koning, Vincent W. Bloks, Annemarieke E. Loot, Dirk Meijer, Peter L. M. Jansen, Folkert Kuipers, Michael Müller	50
16	Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis 1999 ·Gastroenterology ·Peter L. M. Jansen, Sandra Strautnieks, Emmanuel Jacquemin, Michelle Hadchouel, Étienne Sokal, Guido Hooiveld, (unknown), Alie de Jager-Krikken, Folkert Kuipers, Frans Stellaard, C. M. A. Bijleveld, Annette Gouw, Harry van Goor, Richard J. Thompson, Michael Müller	299
17	Up–Regulation of the Multidrug Resistance Genes, Mrp1 And Mdr1b , and Down–Regulation of the Organic Anion Transporter, Mrp2, and the Bile Salt Transporter, Spgp, in Endotoxemic Rat Liver 1998 ·Hepatology ·(unknown), Guido Hooiveld, Hans Koning, Sarah J. Childs, Dirk K. F. Meijer, Han Moshage, Peter L. M. Jansen, Michael Müller	299
18	Gemanagte Partizipation : Qualitätszirkel in der deutschen und der französischen Automobilindustrie 1993 ·Social Science Open Access Repository (GESIS – Leibniz Institute for the Social Sciences) ·(unknown), Peter L. M. Jansen, Leo Kißler	6
19	EVIDENCE OF METABOLIC ACTIVITY OF ADULT AND FETAL RAT HEPATOCYTES TRANSPLANTED INTO SOLID SUPPORTS 1992 ·Transplantation ·Inne Borel-Rinkes, A. Bijma, (unknown), M. Sinaasappel, Frans J. Hoek, Peter L. M. Jansen, Dinko Valerio, Onno T. Terpstra	18
20	Auxiliary liver transplantation in jaundiced rats with UDP-glucuronyltransferase deficiency and defective hepatobiliary transport 1989 ·Journal of Hepatology ·Peter L. M. Jansen, F. Dan Hess, Wilbert H.M. Peters, Emile B. Koenders, (unknown), Frans H.M. Corstens	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact